Skip to main content
. 2018 Mar 20;18(1):58–68. doi: 10.5230/jgc.2018.18.e5

Fig. 2.

Fig. 2

RFS according to pathologic stage. The 3-year RFS was 98.1% in stage IIA (n=109), 85.0% in stage IIB (n=83), 87.4% in stage IIIA (n=96), 83.5% in stage IIIB (n=91), and 62.5% in stage IIIC (n=81).

RFS = relapse-free survival.